{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,11]],"date-time":"2026-10-11T03:03:47Z","timestamp":1791687827435,"version":"4.3.4"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2019,10,24]],"date-time":"2019-10-24T00:00:00Z","timestamp":1571875200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,10,24]],"date-time":"2019-10-24T00:00:00Z","timestamp":1571875200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["81571706"],"award-info":[{"award-number":["81571706"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100004543","name":"China Scholarship Council","doi-asserted-by":"publisher","award":["201806100126"],"award-info":[{"award-number":["201806100126"]}],"id":[{"id":"10.13039\/501100004543","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Imaging Biol"],"published-print":{"date-parts":[[2020,10]]},"DOI":"10.1007\/s11307-019-01443-1","type":"journal-article","created":{"date-parts":[[2019,10,25]],"date-time":"2019-10-25T18:24:32Z","timestamp":1572027872000},"page":"1161-1169","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["PET Imaging of Vesicular Monoamine Transporter 2 in Early Diabetic Retinopathy Using [18F]FP-(+)-DTBZ"],"prefix":"10.1007","volume":"22","author":[{"given":"Jun","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ping","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong","family":"Bao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiang","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xingdang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,10,24]]},"reference":[{"key":"1443_CR1","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1016\/S0140-6736(09)62124-3","volume":"9735","author":"N Cheung","year":"2010","unstructured":"Cheung N, Mitchell P, Wong TY (2010) Diabetic retinopathy. Lancet 9735:124\u2013136","journal-title":"Lancet"},{"key":"1443_CR2","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1016\/j.pop.2015.05.005","volume":"3","author":"AM Hendrick","year":"2015","unstructured":"Hendrick AM, Gibson MV, Kulshreshtha A (2015) Diabetic retinopathy. Prim Care 3:451\u2013464","journal-title":"Prim Care"},{"key":"1443_CR3","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1136\/bjo.2010.196071","volume":"2","author":"SJ Glover","year":"2012","unstructured":"Glover SJ, Burgess PI, Cohen DB et al (2012) Prevalence of diabetic retinopathy, cataract and visual impairment in patients with diabetes in sub-Saharan Africa. Br J Ophthalmol 2:156\u2013161","journal-title":"Br J Ophthalmol"},{"key":"1443_CR4","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1111\/j.1755-3768.2010.01998.x","volume":"3","author":"V Sundling","year":"2012","unstructured":"Sundling V, Platou CG, Jansson RW et al (2012) Retinopathy and visual impairment in diabetes, impaired glucose tolerance and normal glucose tolerance: the Nord-Trondelag Health Study (the HUNT study). Acta Ophthalmol 3:237\u2013243","journal-title":"Acta Ophthalmol"},{"key":"1443_CR5","doi-asserted-by":"publisher","first-page":"2401","DOI":"10.2337\/db05-1635","volume":"9","author":"DA Antonetti","year":"2006","unstructured":"Antonetti DA, Barber AJ, Bronson SK et al (2006) Diabetic retinopathy: seeing beyond glucose-induced microvascular disease. Diabetes 9:2401\u20132411","journal-title":"Diabetes"},{"key":"1443_CR6","doi-asserted-by":"publisher","first-page":"1496","DOI":"10.1038\/eye.2009.108","volume":"7","author":"TM Curtis","year":"2009","unstructured":"Curtis TM, Gardiner TA, Stitt AW (2009) Microvascular lesions of diabetic retinopathy: clues towards understanding pathogenesis? Eye (Lond) 7:1496\u20131508","journal-title":"Eye (Lond)"},{"key":"1443_CR7","doi-asserted-by":"publisher","first-page":"1156","DOI":"10.1167\/iovs.10-6293","volume":"2","author":"AJ Barber","year":"2011","unstructured":"Barber AJ, Gardner TW, Abcouwer SF (2011) The significance of vascular and neural apoptosis to the pathology of diabetic retinopathy. Invest Ophthalmol Vis Sci 2:1156\u20131163","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"1443_CR8","doi-asserted-by":"publisher","first-page":"108328","DOI":"10.1155\/2011\/108328","volume":"2011","author":"Y Ozawa","year":"2011","unstructured":"Ozawa Y, Kurihara T, Sasaki M et al (2011) Neural degeneration in the retina of the streptozotocin-induced type 1 diabetes model. Exp Diabetes Res 2011:108328","journal-title":"Exp Diabetes Res"},{"key":"1443_CR9","doi-asserted-by":"publisher","first-page":"57","DOI":"10.4239\/wjd.v1.i2.57","volume":"2","author":"M Villarroel","year":"2010","unstructured":"Villarroel M, Ciudin A, Hernandez C, Simo R (2010) Neurodegeneration: an early event of diabetic retinopathy. World J Diabetes 2:57\u201364","journal-title":"World J Diabetes"},{"key":"1443_CR10","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/j.visres.2017.06.014","volume":"139","author":"AJ Barber","year":"2017","unstructured":"Barber AJ, Baccouche B (2017) Neurodegeneration in diabetic retinopathy: potential for novel therapies. Vis Res 139:82\u201392","journal-title":"Vis Res"},{"key":"1443_CR11","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1007\/s10384-006-0326-0","volume":"4","author":"J Kizawa","year":"2006","unstructured":"Kizawa J, Machida S, Kobayashi T et al (2006) Changes of oscillatory potentials and photopic negative response in patients with early diabetic retinopathy. Jpn J Ophthalmol 4:367\u2013373","journal-title":"Jpn J Ophthalmol"},{"key":"1443_CR12","doi-asserted-by":"publisher","first-page":"E2655","DOI":"10.1073\/pnas.1522014113","volume":"19","author":"EH Sohn","year":"2016","unstructured":"Sohn EH, van Dijk HW, Jiao C et al (2016) Retinal neurodegeneration may precede microvascular changes characteristic of diabetic retinopathy in diabetes mellitus. Proc Natl Acad Sci U S A 19:E2655\u2013E2664","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1443_CR13","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1159\/000333220","volume":"4","author":"A Verma","year":"2012","unstructured":"Verma A, Raman R, Vaitheeswaran K et al (2012) Does neuronal damage precede vascular damage in subjects with type 2 diabetes mellitus and having no clinical diabetic retinopathy? Ophthalmic Res 4:202\u2013207","journal-title":"Ophthalmic Res"},{"key":"1443_CR14","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1007\/s11427-015-4856-x","volume":"6","author":"AJ Barber","year":"2015","unstructured":"Barber AJ (2015) Diabetic retinopathy: recent advances towards understanding neurodegeneration and vision loss. Sci China Life Sci 6:541\u2013549","journal-title":"Sci China Life Sci"},{"key":"1443_CR15","doi-asserted-by":"publisher","first-page":"2861","DOI":"10.1167\/iovs.10-5960","volume":"6","author":"A Lecleire-Collet","year":"2011","unstructured":"Lecleire-Collet A, Audo I, Aout M et al (2011) Evaluation of retinal function and flicker light-induced retinal vascular response in normotensive patients with diabetes without retinopathy. Invest Ophthalmol Vis Sci 6:2861\u20132867","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"1443_CR16","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1023\/B:DOOP.0000019487.88486.0a","volume":"1","author":"P Witkovsky","year":"2004","unstructured":"Witkovsky P (2004) Dopamine and retinal function. Doc Ophthalmol 1:17\u201340","journal-title":"Doc Ophthalmol"},{"key":"1443_CR17","first-page":"959","volume":"22","author":"H Lahouaoui","year":"2016","unstructured":"Lahouaoui H, Coutanson C, Cooper HM, Bennis M, Dkhissi-Benyahya O (2016) Diabetic retinopathy alters light-induced clock gene expression and dopamine levels in the mouse retina. Mol Vis 22:959\u2013969","journal-title":"Mol Vis"},{"key":"1443_CR18","doi-asserted-by":"publisher","first-page":"1418","DOI":"10.1167\/iovs.15-17999","volume":"3","author":"JM Moore-Dotson","year":"2016","unstructured":"Moore-Dotson JM, Beckman JJ, Mazade RE et al (2016) Early retinal neuronal dysfunction in diabetic mice: reduced light-evoked inhibition increases rod pathway signaling. Invest Ophthalmol Vis Sci 3:1418\u20131430","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"1443_CR19","doi-asserted-by":"publisher","first-page":"4242","DOI":"10.1523\/JNEUROSCI.5436-03.2004","volume":"17","author":"P Witkovsky","year":"2004","unstructured":"Witkovsky P, Veisenberger E, Haycock JW et al (2004) Activity-dependent phosphorylation of tyrosine hydroxylase in dopaminergic neurons of the rat retina. J Neurosci 17:4242\u20134249","journal-title":"J Neurosci"},{"key":"1443_CR20","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1167\/iovs.17-22692","volume":"1","author":"MK Kim","year":"2018","unstructured":"Kim MK, Aung MH, Mees L et al (2018) Dopamine deficiency mediates early rod-driven inner retinal dysfunction in diabetic mice. Invest Ophthalmol Vis Sci 1:572\u2013581","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"1443_CR21","doi-asserted-by":"publisher","first-page":"3143","DOI":"10.1167\/iovs.05-1376","volume":"7","author":"MJ Gastinger","year":"2006","unstructured":"Gastinger MJ, Singh RS, Barber AJ (2006) Loss of cholinergic and dopaminergic amacrine cells in streptozotocin-diabetic rat and Ins2Akita-diabetic mouse retinas. Invest Ophthalmol Vis Sci 7:3143\u20133150","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"1443_CR22","doi-asserted-by":"publisher","first-page":"726","DOI":"10.1523\/JNEUROSCI.3483-13.2014","volume":"3","author":"MH Aung","year":"2014","unstructured":"Aung MH, Park HN, Han MK et al (2014) Dopamine deficiency contributes to early visual dysfunction in a rodent model of type 1 diabetes. J Neurosci 3:726\u2013736","journal-title":"J Neurosci"},{"key":"1443_CR23","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1111\/j.1749-6632.2010.05906.x","volume":"1216","author":"LE Eiden","year":"2011","unstructured":"Eiden LE, Weihe E (2011) VMAT2: a dynamic regulator of brain monoaminergic neuronal function interacting with drugs of abuse. Ann N Y Acad Sci 1216:86\u201398","journal-title":"Ann N Y Acad Sci"},{"key":"1443_CR24","doi-asserted-by":"publisher","first-page":"1005","DOI":"10.1124\/pr.114.010397","volume":"4","author":"CL German","year":"2015","unstructured":"German CL, Baladi MG, McFadden LM et al (2015) Regulation of the dopamine and vesicular monoamine transporters: pharmacological targets and implications for disease. Pharmacol Rev 4:1005\u20131024","journal-title":"Pharmacol Rev"},{"key":"1443_CR25","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1007\/s11307-018-1183-1","volume":"5","author":"Y Sun","year":"2018","unstructured":"Sun Y, Zhao N, Liu W et al (2018) Study of vesicular monoamine transporter 2 in myopic retina using [18F]FP-(+)-DTBZ. Mol Imaging Biol 5:771\u2013779","journal-title":"Mol Imaging Biol"},{"key":"1443_CR26","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1148\/radiol.2422051113","volume":"2","author":"TM Blodgett","year":"2007","unstructured":"Blodgett TM, Meltzer CC, Townsend DW (2007) PET\/CT: form and function. Radiology 2:360\u2013385","journal-title":"Radiology"},{"key":"1443_CR27","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1038\/nrneurol.2014.81","volume":"6","author":"H Wood","year":"2014","unstructured":"Wood H (2014) Parkinson disease: 18F-DTBZ PET tracks dopaminergic degeneration in patients with Parkinson disease. Nat Rev Neurol 6:305","journal-title":"Nat Rev Neurol"},{"key":"1443_CR28","doi-asserted-by":"publisher","first-page":"908","DOI":"10.2967\/jnumed.111.100545","volume":"6","author":"MD Normandin","year":"2012","unstructured":"Normandin MD, Petersen KF, Ding YS et al (2012) In vivo imaging of endogenous pancreatic beta-cell mass in healthy and type 1 diabetic subjects using 18F-fluoropropyl-dihydrotetrabenazine and PET. J Nucl Med 6:908\u2013916","journal-title":"J Nucl Med"},{"key":"1443_CR29","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1016\/j.nucmedbio.2006.12.005","volume":"3","author":"MP Kung","year":"2007","unstructured":"Kung MP, Hou C, Goswami R et al (2007) Characterization of optically resolved 9-fluoropropyl-dihydrotetrabenazine as a potential PET imaging agent targeting vesicular monoamine transporters. Nucl Med Biol 3:239\u2013246","journal-title":"Nucl Med Biol"},{"key":"1443_CR30","doi-asserted-by":"publisher","first-page":"16027","DOI":"10.1038\/s41598-018-34388-6","volume":"1","author":"LH Jung","year":"2018","unstructured":"Jung LH, Weng YH, Wen MC et al (2018) Quantitative study of 18F-(+)DTBZ image: comparison of PET template-based and MRI based image analysis. Sci Rep 1:16027","journal-title":"Sci Rep"},{"key":"1443_CR31","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0039041","volume":"6","author":"JS Toomey","year":"2012","unstructured":"Toomey JS, Bhatia S, Moon LT et al (2012) PET imaging a MPTP-induced mouse model of Parkinson's disease using the fluoropropyl-dihydrotetrabenazine analog [18F]-DTBZ (AV-133). PLoS One 6:e39041","journal-title":"PLoS One"},{"key":"1443_CR32","doi-asserted-by":"publisher","first-page":"3595","DOI":"10.1167\/iovs.08-1679","volume":"8","author":"K Kohzaki","year":"2008","unstructured":"Kohzaki K, Vingrys AJ, Bui BV (2008) Early inner retinal dysfunction in streptozotocin-induced diabetic rats. Invest Ophthalmol Vis Sci 8:3595\u20133604","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"1443_CR33","doi-asserted-by":"publisher","first-page":"2706","DOI":"10.1167\/iovs.15-18397","volume":"6","author":"DM Desjardins","year":"2016","unstructured":"Desjardins DM, Yates PW, Dahrouj M et al (2016) Progressive early breakdown of retinal pigment epithelium function in hyperglycemic rats. Invest Ophthalmol Vis Sci 6:2706\u20132713","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"1443_CR34","doi-asserted-by":"publisher","first-page":"1169","DOI":"10.1248\/yakushi.17-00115","volume":"9","author":"N Hiramatsu","year":"2017","unstructured":"Hiramatsu N, Deguchi S, Yoshioka C et al (2017) Evaluation of retinal function in streptozotocin-induced diabetic rats by using the electroretinography and immunohistochemistry methods. Yakugaku Zasshi 9:1169\u20131175","journal-title":"Yakugaku Zasshi"},{"key":"1443_CR35","doi-asserted-by":"publisher","first-page":"319692","DOI":"10.1155\/2015\/319692","volume":"2015","author":"N Pescosolido","year":"2015","unstructured":"Pescosolido N, Barbato A, Stefanucci A, Buomprisco G (2015) Role of electrophysiology in the early diagnosis and follow-up of diabetic retinopathy. J Diabetes Res 2015:319692","journal-title":"J Diabetes Res"},{"key":"1443_CR36","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1177\/1535370216663866","volume":"1","author":"Y Wang","year":"2017","unstructured":"Wang Y, Qin S, Pen G et al (2017) Original research: potential ocular protection and dynamic observation of Polygonatum sibiricum polysaccharide against streptozocin-induced diabetic rats' model. Exp Biol Med (Maywood) 1:92\u2013101","journal-title":"Exp Biol Med (Maywood)"},{"key":"1443_CR37","first-page":"862","volume":"14","author":"S Zhang","year":"2008","unstructured":"Zhang S, Chai FY, Yan H, Guo Y, Harding JJ (2008) Effects of N-acetylcysteine and glutathione ethyl ester drops on streptozotocin-induced diabetic cataract in rats. Mol Vis 14:862\u2013870","journal-title":"Mol Vis"},{"key":"1443_CR38","doi-asserted-by":"publisher","first-page":"892","DOI":"10.1136\/bjo.79.10.892","volume":"10","author":"JN Kirkpatrick","year":"1995","unstructured":"Kirkpatrick JN, Manivannan A, Gupta AK et al (1995) Fundus imaging in patients with cataract: role for a variable wavelength scanning laser ophthalmoscope. Br J Ophthalmol 10:892\u2013899","journal-title":"Br J Ophthalmol"},{"key":"1443_CR39","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1369\/jhc.5A6739.2005","volume":"2","author":"M Anlauf","year":"2006","unstructured":"Anlauf M, Schafer MK, Schwark T et al (2006) Vesicular monoamine transporter 2 (VMAT2) expression in hematopoietic cells and in patients with systemic mastocytosis. J Histochem Cytochem 2:201\u2013213","journal-title":"J Histochem Cytochem"}],"container-title":["Molecular Imaging and Biology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11307-019-01443-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11307-019-01443-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11307-019-01443-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,10,22]],"date-time":"2020-10-22T23:20:55Z","timestamp":1603408855000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11307-019-01443-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,10,24]]},"references-count":39,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2020,10]]}},"alternative-id":["1443"],"URL":"https:\/\/doi.org\/10.1007\/s11307-019-01443-1","relation":{},"ISSN":["1536-1632","1860-2002"],"issn-type":[{"value":"1536-1632","type":"print"},{"value":"1860-2002","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,10,24]]},"assertion":[{"value":"24 October 2019","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"All experiment procedures were approved by the Administrative Panel on Laboratory Animal Care (APALC) at Fudan University.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}}]}}